 |
| 2019 CCS Ideas and Clinical Trials and Cohort Studies grant recipients. L-R, upper row: Catherine Carmichael, Ross Dickins, Justin Hamilton, Christoph Hagemeyer. L-R lower row: Phil Kantharidis, Marcus Robinson, Joseph Doyle, Paul Myles |
CCS researchers have been awarded a total of $12.7 million across 8 grants (6 Ideas, 2 CTCS). CCS areas of expertise which have been funded this round range across the discipline areas of blood diseases, diabetes, infectious diseases, immunology and surgery. Funding for these grants will begin in 2020.
Monash University has been awarded more than $76 million in this round of National Health and Medical Research Council (NHMRC) funding. Link
Ideas grant recipients
- Dr Catherine Carmichael, Australian Centre for Blood Diseases group
Novel therapeutic strategies for an aggressive subtype of Acute Myeloid Leukaemia. $1,385,686 2020-2024 - Associate Professor Ross Dickins, Australian Centre for Blood Diseases group
Mechanisms of AML differentiation therapy response and relapse. $808,880 across 2020-2024 - Associate Professor Christoph Hagemeyer, Australian Centre for Blood Diseases group
Self-regulated, glucose-responsive nanomaterials for smart insulin delivery. $944,796 across 2020-2024. See feature story - Associate Professor Justin Hamilton, Australian Centre for Blood Diseases group
Inhibition of the platelet thrombin receptor PAR4 to prevent thrombosis in coronary artery disease $1,148,011 across 2020-2024 - Dr Phillip Kantharidis, Department of Diabetes group
Targeting pro-resolution pathways to reverse diabetic kidney disease. $1,046,310 2020-2024 - Dr Marcus Robinson, Department of Immunology and Pathology group
Defining sources of IgE in chronic allergic diseases. $731,920 across 2020-2024
Clinical Trials and Cohort Studies
- Professor Paul Myles, Anaesthesia and Perioperative Medicine Tranexamic acid to Reduce Infection after Gastrointestinal Surgery – the TRIGS Trial. $5,196,595 across 2020-2024. See feature story
- Dr Joseph Doyle, Infectious Diseases group
Same-visit hepatitis C testing and treatment to accelerate cure among people who inject drugs: a cluster randomised controlled trial. $1,459,971 across 2020-2022
No comments:
Post a Comment
Thankyou for your comment. We moderate all messages and may take a little time to review your comment. Please email inquiries to ccs.comms@monash.edu.